Polymorphism in sodium-channel alpha 1-subunit (SCN1A) predicts response, TTP, survival, and toxicity in patients with metastatic colorectal cancer treated with 5-FU/oxaliplatin.
暂无分享,去创建一个
H. Lenz | A. El-Khoueiry | W. Zhang | W. Fazzone | D. Yang | M. Azuma | A. Schultheis | M. Gordon | F. Nagashima | S. Iqbal